HEADACHES AFTER Bone Marrow Transplant

Similar documents
Great Ormond Street Hospital for Children. Patient Transfer. Penny Eyton-Jones TLM, Great Ormond Street NHS Foundation Trust

Blood Component Testing and Labeling

Supporting solid organ transplants: Challenges for Blood Transfusion Labs

Carol Cantwell Blood Transfusion Laboratory Manager St Mary s Hospital, ICHNT

Non-Medical Authorisation Course

ABO and H Blood Groups. Terry Kotrla, MS, MT(ASCP)BB 2010

An Approach to the Patient Refractory to Platelets Transfusion. Harold Alvarez, MD

The testing of Donated Blood and Components at NHSBT

ABO INCOMPATILIBITY AND TRANSPLANTATION

All you wanted to know about transfusion support for transplants

TRANSFUSION SAFETY 101 ARE YOU SMARTER THAN A BLOOD BANKER?

Transfusion Medicine Kris0ne Kra1s, M.D.

Blood Components & Indications for Transfusion. Neda Kalhor

What makes up our blood?

BLOOD GROUPS TOPIC IN BLOOD GROUPS: ABO BLOOD GROUP SYSTEM, RH SYSTEM AND RED KENDRIYA VIDYALAYA NELLORE DATE & TIME: 7 TH APRIL 2018

BLOOD TRANSFUSION. Dr Lumka Ntabeni

Antibody identification. Antibody specificity

Direct Antiglobulin Test (DAT)

Blood transfusion. Dr. J. Potgieter Dept. of Haematology NHLS - TAD

RHESUS BLOOD GROUP SYSTEM (Author: Alvine Janse van Rensburg; ND Biomedical Technology-Microbiology, Haematology, Chemistry)

REFERENCE LABORATORY. Regular Hours - Monday through Friday 8:00 AM to 4:00 PM. On-Call Staff - Evenings, Nights, Weekend and Holidays.

Blood & Blood Product Administration

Retrospective analysis of ABO discrepancies among patients and blood donors in a tertiary care hospital

All institutions that transfuse blood components and products should implement national and local policies and written procedures for:

UKGS TRANSFUSION SERVICE PRODUCTS AND AVAILABILITY

Transfusion Awareness

Definitions of Current SHOT Categories & What to Report

Transfusion Errors in Transplant Recipients. Paula Bolton-Maggs Alison Watt Debbi Poles Serious Hazards of Transfusion

CASE STUDIES IN CLINICAL APPLICATIONS OF THERAPEUTIC PLASMA EXCHANGE

HLA Selected Platelets

Apheresis: Transfusion Indications. Sasha Wilson: Transfusion Senior Nurse

T. Trimpe Forensic Science

How much blood is in the human. About 5 liters. body?

It s not just allo-antibodies that a red cell transfusion can stimulate

Basel - 6 September J.-M. Tiercy National Reference Laboratory for Histocompatibility (LNRH) University Hospital Geneva

Specific Requirements

Transfusion Medicine Kris0ne Kra1s, M.D.

IMMUNOBIOLOGY OF TRANSPLANTATION. Wasim Dar

Management of platelet refractory patients, why does your patient keep on bleeding? Dr Colin Brown, H&I Dept, NHSBT Colindale

CHAPTER 10 BLOOD GROUPS: ABO AND Rh

NLBCP-017 INDIRECT ANTIGLOBULIN CROSSMATCH TUBE METHOD. Issuing Authority

Pearson's Comprehensive Medical Assisting Administrative and Clinical Competencies

Transfusion support for the oncology patient

Blood and Marrow Transplant (BMT) for Sickle Cell Disease

The Use of HLA /HPA Selected Platelets

Blood Types and Genetics

Blood Transfusion. There are three types of blood cells: Red blood cells. White blood cells. Platelets.

Transplants. Mickey B. C. Koh

Guidelines for Requesting Type and Screen Testing for Elective Surgical Adult Patients within the WRHA Surgery Program

Problems with Standardisation of Automated Titration Local Level Implementation - ISO 15189

Significance of Antibodies and appropriate selection of red cells for transfusion Chris Elliott Haematology Service manager

CTYOMEGALOVIRUS (CMV) - BACKGROUND

Lecture 8. Heart and Circulatory System. Lecture 8

Lab Guide Blood Bank Section Lab Guide


Transfusion challenges in transplantation fields

John Goodwin. H&I Laboratory, National Blood Service, Sheffield. FIMLS, MPhil, DipRCPath. John Goodwin, H&I Department, Sheffield

Risks and Benefits of Blood Transfusions. Objectives. Red Cells (Erythrocytes) Understand the following:

Guidelines for the Management of Platelet Transfusion Refractoriness GUIDELINES FOR THE MANAGEMENT OF PLATELET TRANSFUSION REFRACTORINESS

Trends in Hematopoietic Cell Transplantation. AAMAC Patient Education Day Oct 2014

Private Patients Pricelist

Crossmatching and Issuing Blood Components; Indications and Effects.

Newcastle upon Tyne Blood Transfusion Course

Lecture 1: Characteristics & Testing Of Blood

Essential Transfusion. Medical Students

State Patients Pricelist. 1 April March 2019

Transfusion support in Transplantation

Plasma Red blood cells White blood cells. Leucocytes KEYWORDS Phagocytes

SHOT Data. Why are SCT Patients a Special Group? Transfusion Problems in Stem Cell Transplant (SCT) Patients. BMT Patients are not a Special Group

Essentials of Blood Group Antigens and Antibodies

Private Patients Pricelist. 1 April December 2018

INFORMATION ONLY Changes to Requesting HLA/HPA Selected Apheresis Platelets Customer Letter #

CURRENT COURSE OFFERINGS

BMTCN REVIEW COURSE PRE-TRANSPLANT CARE

SICKLE CELL AWARENESS. The Sickle Cell Society has produced the following information leaflets available at sicklecellsociety.org

Post-Transplant Vaccination and Re-Immunisation Procedure

CrackCast Episode 7 Blood and Blood Components

Guide to the preparation, use and quality assurance of blood components

XIV. HLA AND TRANSPLANTATION MEDICINE

INVESTIGATION OF ADVERSE TRANSFUSION REACTIONS NLBCP-006. Issuing Authority

The role of HLA in Allogeneic Hematopoietic Stem Cell Transplantation and Platelet Refractoriness.

Patient Blood Management. Peter Freeman Patient Blood Management Officer Clinical Operations Hunter New England LHD.

Chapter 13 The Blood

Chapter 10. Histocompatibility Testing

The MHC and Transplantation Brendan Clark. Transplant Immunology, St James s University Hospital, Leeds, UK

FIT Board Review Corner March 2016

Transfusion Medicine (Comprehensive, Limited) J, J1

ABO mismatched Renal Transplants

AIHA The Laboratory Perspective on Testing. Tom Bullock Joint UK NEQAS (BTLP) & BBTS BBT SIG Annual Meeting 20 th November 2018

Immunohematology (Introduction) References: -Blood Groups and Red Cell Antigens (Laura Dean) -Cellular and molecular immunology, 8 th edition

Duration: 12 months May to April

Blood ESSENTIALS OF HUMAN ANATOMY & PHYSIOLOGY ELAINE N. MARIEB EIGHTH EDITION

Name: Per: Date: Unit 9a: Blood (Composition/Types/Inheritance)

Passenger Lymphocyte Syndrome (case presentation) Dr. Namal Bandara Kings College Hospital

Provision of Red Cell Transfusion Support for Transfusion Dependent Patients

Disclosures. Committee on Blood and Blood Products) Co-investigator CBS Small Project. in Solid Organ Transplant Recipients

Factors Influencing Haematopoietic Progenitor cell transplant outcome Optimising donor selection

Transfusion Medicine Potpourri. BUMC - Phoenix Internal Medicine Residents September 29, 2015

Histocompatibility. HLA Serologic Typing (Class I/II) ABO, HLAS, HLAS Surveys & Anatomic Pathology Education Programs

Transcription:

HEADACHES AFTER Bone Marrow Transplant This is the first slide Peter Russell, Supervising Scientist, Transfusion Haematology, Queensland Pathology Central RBWH, Herston Rd, HERSTON, QLD. 4029, Australia. Investigate preliminary testing for BMT patients Decipher result for problem patients The ABO Rh and antibody status of patient and donor is determined. The patient and donor are CMV tested. The first problem with BMT patients is determining product support. With a major ABO mismatch, the anti A/B titres are performed on the recipient. Recipient with a high anti A/B titre. Patient plasmapheresis performed using the appropriate ABO plasma. All BMT patients receive Irradiated product from the transplant date A protocol is prepared for the patients treatment and circulated to all departments involved Computer is adjusted to ensure the right products are supplied.

Bone Marrow Transplant Testing Donor Blood Group Recipient Blood Group Titre Testing O O Not required A Donor Anti A B Donor Anti B AB Donor Anti A&B A O Recipient Anti A A Not required B Recipient Anti B, Donor Anti A AB Donor Anti B 2

Table 5.: Blood component selection in allogeneic HPCT Bone Marrow Transplant Testing Donor Blood Group Recipient Blood Group Titre Testing B O Recipient Anti B A Recipient Anti B, Donor Anti A B Not required AB Donor Anti A AB O Recipient Anti A&B A Recipient Anti B B Recipient Anti A AB Not required ***Rh D negative blood group - requires Du Test ABO Match Minor ABO Mismatch PBC Platelets + Plasma Donor Recipient st choice 2 nd choice st choice 2 nd choice platelets 2 nd choice plasma O O O - O A A A A A O A O AB B B B O B O AB AB AB AB A AB A A O A O - A O AB O B O - B O AB O AB O - AB O A A AB A O AB A A B AB B O AB B B Neg Pos Neg - Neg Pos Major ABO Mismatch PBC Platelets + Plasma Donor Recipient st choice 2 nd choice st choice 2 nd choice platelets 2 nd choice plasma A O O - A O AB B O O - B O AB AB O O - AB O A AB A A O AB A A AB B B O AB B B Selecting plasma group for plasma exchange Recipient group Recipient High titre for anti Donor ABO group Plasma ABO group ABO antigens (substance) present O A A A A O B B B B Minor A B O - AB B A Major B A O - AB A B A B B B B B A A A A Rhesus Pos Neg Neg - Neg Pos Neg Pos Neg - Neg Pos 3

Grouping is not the only problem for BMT patients 2 2 4

. 2. 3. 4. 5. Results have been entered correctly Check that correct reagent added to correct well/tube Check that QC performed and reagents passed Check clinical history Find previous results 2 4 5 5

Patient Male born 960 Request: Group and hold Clinical history on request: Anaemic 2 3 6

Antibody register Clinical notes Patient 2 Male born 982 Request: Group and hold Clinical history on request: Anaemic. 2. 3. Group B Neg transfused O Neg? Group O Neg transfused B Neg? BMT Rec. B Neg Donor O Neg converting? 4. BMT Rec. O Neg Donor B Neg converting? 2 3 7

Transfused IVIG Transfused IVIG 2 Transfused IVIG on 4/6/20 2 8

Patient 3 Female born 945 Patient for Bone Marrow transplant 9

May 2008 Patient presents again 0

Patient is anaemic and they request 2 units! What do we transfuse? Rh Negative? Rh Positive? Patient 4 Male born 982 Request: Group and Crossmatch Clinical history on request: Bleeding and anaemic

. 2. 3. 4. 5. Group AB Pos transfused A Neg? Group AB pos transfused O Neg? Group AB neg transfused O Pos? BMT: Rec. A Pos Donor B Neg converting? BMT: Rec. B Pos Donor A Neg converting? 6. Group AB Pos transfused O Neg with a cold alloantibody? 2 3 2 3 2

Patient 5 Female born 969 Request: Group and hold Clinical history on request: Anaemic. 2. 3. 4. 5. Group A Pos with an anti A Group O Pos with acquired A? Group AB neg transfused O Pos? BMT Rec. A Pos Donor O Pos converting? BMT Rec. O Pos Donor A Pos converting? 6. Group A Pos with a cold alloantibody? 2 3 4 3

2 4

2 5

2 6

SUMMARY OF THIS PATIENT Patient initially group A Patient had two group O transplants A cells positive cold anti e (very transient) A cells positive to transfused anti A Patient 6 Male born 982 Request: Group and hold Clinical history on request: Anaemic The loss of Anti A and anti B end 7

. 2. 3. 4. 5. Group AB Pos transfused A Neg? Group AB pos transfused O Neg? Group AB neg transfused O Pos? BMT Rec. A Pos Donor B Neg converting? BMT Rec. B Pos Donor A Neg converting? 6. Group AB Pos transfused O Neg with a cold alloantibody? 8

Q. what is the most important process when performing blood bank testing? A. record the results you get not what might fit or imagine weak reactions. Q. What are the essential data when interpreting unexpected transfusion results A. patient clinical history historical results Q. Results that are not expected, what is the first question to be asked? A. Has there been an error? Errors are more common than exotic blood group Q. In interpreting transfusion results do you rely on the test results only? A. NO! as these can be distorted by clinical conditions and patient treatment. Q. Do complex transfusion problems only happen in large laboratories between 9-5pm on working days? A. No they can occur at any time of the day or night in large, medium and small sized laboratories. THE END 9

20